Search
Sort Results
Filter by Specific Population
Filter by Topic
Filter by Resource Category
Search results
Current filters: Hepatitis C drugs, Hepatitis C
55 search results
- FDA—Rare cases of liver injury with some hepatitis C treatments
-
2019, CATIE
Research summary - Webpage - Maviret for hepatitis C treatment enters the Ontario drug formulary
-
2019, CATIE
Research summary - Webpage - About HCV drugs in Canada
-
From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage - Maviret for people with HCV and chronic kidney disease
-
From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage - Experience with Maviret in northern Italy
-
From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage - Germany—experience with Maviret after licensure
-
From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage - HCV cure and the long road to recovery
-
From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage - HCV treatment in advanced liver disease
-
From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage - Hepatitis C treatment in the new DAA era: frontline implications
-
2020, CATIE
Webinar - Video - Vosevi (sofosbuvir + velpatasvir + voxilaprevir)
-
2019, CATIE
Fact sheet - Webpage
